Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart patients get a helping hand: new care model boosts medication adherence

NCT ID NCT07346664

Disease control Sponsor: Qing Wang Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a transitional care model for 108 patients with coronary heart disease who had a stent procedure. The program used structured follow-up and WeChat-based education to help patients take their medications correctly and improve self-care. Researchers measured medication adherence, self-efficacy, and cholesterol levels to see if the extra support made a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
transitional care model (structured follow-up and education via WeChat)
What this could lead to
If it works, this could point toward a simple, low-cost way to help heart patients stay on track with their medications and lifestyle changes after a procedure.
What could go wrong
This is a small, single-center study with no blinding, so results may not apply to all heart patients. The intervention is behavioral, not a drug, so effects may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

108 people

The number who actually took part.

Started

Jul 2022

Finished

May 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

47 to 58 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * patients clinically diagnosed with CHD according to established diagnostic criteria * patients who met the World Health Organization (WHO) indications for PCI * complete clinical data available Exclusion Criteria: * Patients with cognitive impairment * Patients with incomplete follow-up data. * Patients with comorbid malignancy * Patients with severe hepatic * Patients with renal insufficiency

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary heart disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

coronary artery disorder Coronary Disease Medication Adherence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coronary heart disease Lipid profile Medication adherence Self efficacy Transitional care model

Contacts and locations

Locations

  • Northern Jiangsu People's Hospital Affiliated to Yangzhou University

    Yangzhou, Jiangsu, 225001, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.